Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.51 |
| ▸ | CA2 | P00918 | 4/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.45 |
| ▸ | MEN1 | O00255 | 6/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.45 |
| ▸ | MAPT | P10636 | 4/20 | 0.45 |
| ▸ | CA12 | O43570 | 3/20 | 0.45 |
| ▸ | CA9 | Q16790 | 3/20 | 0.45 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.45 |
| ▸ | CA7 | P43166 | 2/20 | 0.45 |
| ▸ | EGFR | P00533 | 1/20 | 0.45 |
| ▸ | BRD4 | O60885 | 1/20 | 0.45 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.45 |
| ▸ | MB | P02144 | 1/20 | 0.45 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.45 |
| ▸ | CA3 | P07451 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | RARG | P13631 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1143828 | 0.98 | CA1 (0.50) | CA1CA2ALDH1A1MEN1KMT2A | |
| SCHEMBL3989776 | 0.86 | CA1 (0.45) | CA1CA2ALDH1A1MEN1KMT2A | |
| SCHEMBL11650926 | 0.84 | ALDH1A1 (0.47) | CA1CA2ALDH1A1MEN1KMT2A | |
| SCHEMBL9780021 | 0.84 | KMT2A (0.57) | CA1CA2ALDH1A1MEN1KMT2A | |
| SCHEMBL1372423 | 0.83 | POLB (0.63) | CA1CA2ALDH1A1MEN1KMT2A | |
| SCHEMBL11884077 | 0.82 | CA1 (0.42) | CA1CA2ALDH1A1MEN1KMT2A | |
| SCHEMBL1733109 | 0.82 | ALDH1A1 (0.43) | CA1CA2ALDH1A1MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL10541037 | 0.82 | KMT2A (0.56) | CA1CA2ALDH1A1MEN1KMT2A | |
| SCHEMBL4142658 | 0.82 | ALDH1A1 (0.51) | ALDH1A1MEN1KMT2AMAPTPOLB | |
| SCHEMBL9779998 | 0.82 | MAPT (0.59) | CA1CA2ALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 485 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120699943-B | Penicillin acylase for synthesizing beta-lactam antibiotics | 浙江师范大学行知学院 | 2026-05-15 | — | — | CN | claimed |
| US-12473580-B1 | One-step method for synthesizing amoxicillin from penicillin or salt thereof through enzyme catalysis | XINGZHI COLLEGE ZHEJIANG NORMAL UNIVERSITY (CN) | 2025-11-18 | — | — | US | claimed |
| US-12404534-B1 | Method for separating amoxicillin and phenylacetic acid from reaction solution in one-step enzymatic synthesis of amoxicillin | XINGZHI COLLEGE ZHEJIANG NORMAL UNIVERSITY (CN) | 2025-09-02 | — | — | US | claimed |
| US-12312371-B2 | Optically-active 2-amino-phosphonoalkane acid, optically-active 2-amino-phosphonoalkane acid salt, and hydrates of these | NAHLS CORPORATION CO., LTD. (JP) | 2025-05-27 | — | — | US | claimed |
| CN-119242757-B | Method for separating amoxicillin and phenylacetic acid from reaction liquid for preparing amoxicillin by enzyme catalysis one-step method | 浙江师范大学行知学院 | 2025-05-16 | — | — | CN | claimed |
| CN-119753075-A | Method for preparing cefprozil by using enzyme method | 长沙酶森生物科技有限公司 | 2025-04-04 | — | — | CN | claimed |
| CN-118995868-B | Method for synthesizing amoxicillin from penicillin or salt thereof by enzyme catalysis one-step method | 浙江师范大学行知学院 | 2025-03-28 | — | — | CN | claimed |
| CN-119306623-A | Crystallization process of D-p-hydroxyphenylglycine methyl ester | 霍山维康生物科技有限公司 | 2025-01-14 | — | — | CN | claimed |
| CN-119242757-A | Method for separating amoxicillin and phenylacetic acid from reaction liquid for preparing amoxicillin by enzyme catalysis one-step method | 浙江师范大学行知学院 | 2025-01-03 | — | — | CN | claimed |
| CN-115490706-B | Preparation method of amoxicillin crystal | 国药集团威奇达药业有限公司 | 2024-12-13 | — | — | CN | claimed |
| US-6824786-B2 | TOPICAL APPLYING COSMETIC | YU RUEY J (US) | 2004-11-30 | — | — | US | claimed |
| US-20040220264-A1 | Bioavailability and improved delivery of acidic pharmaceutical drugs | YU RUEY J | 2004-11-04 | — | — | US | claimed |
| WO-2004082628-A2 | IMPROVED BIOAVAILABILITY AND IMPROVED DELIVERY OF ACIDIC PHARMACEUTICAL DRUGS | YU RUEY J (US) | 2004-09-30 | — | — | WO | claimed |
| EP-1455734-A1 | COMPOSITIONS COMPRISING PHENYL-GLYCINE DERIVATIVES | Yu, Ruey J., Dr. (US) | 2004-09-15 | — | — | EP | claimed |
| US-20030108496-A1 | Compositions comprising phenyl-glycine derivatives | YU RUEY J (US) | 2003-06-12 | — | — | US | claimed |
| WO-2003045338-A1 | COMPOSITIONS COMPRISING PHENYL-GLYCINE DERIVATIVES | YU RUEY J (US) | 2003-06-05 | — | — | WO | claimed |
| EP-0960945-B1 | Enzymatic process for producing beta-lactam antibiotics involving product recovery at pH 1 in the presence of immobilized penicillin amidase | UNIFAR KIMYA SANAYII VE TICARE (TR) | 2002-09-04 | — | — | EP | claimed |
| US-6218138-B1 | REACTING AMINO-BETA-LACTAM COMPONENT AND CORRESPONDING AMINO-GROUP CONTAINING ACYLATING SIDE CHAIN COMPONENT IN PRESENCE OF BIOCATALYSTTO FORM ANTIBIOTIC, SOLUBILIZING BY ADDING ACID WHICH DEACTIVATES ENZYME; ENZYME IS REUSEDENZYME | UNIFAR KIMYA SANAYI VE TICARET A.S. (TM) | 2001-04-17 | — | — | US | claimed |
| EP-0960945-A2 | Enzymatic process for producing beta-lactam antibiotics involving product recovery at pH 1 in the presence of immobilized penicillin amidase | Unifar Kimya Sanayii ve Ticaret A.S (TR) | 1999-12-01 | — | — | EP | claimed |
| EP-0567323-A2 | Improved process for preparing cephalosporins | ELI LILLY AND COMPANY (US) | 1993-10-27 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030108496-A1 | Compositions comprising phenyl-glycine derivatives | GRHPR, ARL1, SUCLG1 | CA1 3257/4885CA2 1324/4885ALDH1A1 1110/4885 |
| US-12473580-B1 | One-step method for synthesizing amoxicillin from penicillin or salt thereof through enzyme catalysis | APEH, DNPEP, PHYKPL | CA1 1092/4885CA2 497/4885ALDH1A1 492/4885 |
| US-12404534-B1 | Method for separating amoxicillin and phenylacetic acid from reaction solution in one-step enzymatic synthesis of amoxicillin | APEH, NAAA, PEPD | CA1 1950/4885CA2 1001/4885ALDH1A1 698/4885 |
| US-12312371-B2 | Optically-active 2-amino-phosphonoalkane acid, optically-active 2-amino-phosphonoalkane acid salt, and hydrates of these | AASDHPPT, PHYKPL, PKD2 | CA1 310/4885CA2 128/4885ALDH1A1 255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.